n(6)-carboxymethyllysine has been researched along with Atheroma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Pang, M; Shao, C; Sun, Z; Wang, Z; Zhang, L | 1 |
| Aikawa, H; Eto, A; Hanada, H; Hiraoka, F; Iko, M; Inoue, R; Kazekawa, K; Kiyomi, F; Mitsutake, T; Nagai, R; Nii, K; Sakamoto, K; Sakata, N; Shirakawa, JI; Tsutsumi, M | 1 |
| Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J | 1 |
| Barbé, F; Benabdelhak, I; Bermúdez-López, M; Betriu, À; Colàs-Campàs, L; Farràs, C; Fernández, E; Hernández, C; Hernández, M; Jové, M; Kerkeni, M; Lecube, A; Manuel Valdivielso, J; Martínez-Alonso, M; Miquel, E; Ortega, M; Pamplona, R; Polanco, D; Portero-Otin, M; Purroy, F; Rius, F; Sánchez, E; Sánchez-de-la-Torre, M; Simó, R; Suárez, G; Torres, G; Yeramian, A | 1 |
4 other study(ies) available for n(6)-carboxymethyllysine and Atheroma
| Article | Year |
|---|---|
Nε-Carboxymethyl-Lysine Mediates Vascular Calcification in Diabetes Caused by Impaired Osteoclastic Resorption Activity Through NFATc1-GNPTAB.
Topics: Bone Resorption; Cell Differentiation; Diabetes Mellitus; Humans; NFATC Transcription Factors; Osteoclasts; Plaque, Atherosclerotic; Transcription Factors; Transferases (Other Substituted Phosphate Groups); Vascular Calcification | 2023 |
N
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Arteries; Carotid Stenosis; Chi-Square Distribution; Chromatography, Liquid; Diffusion Magnetic Resonance Imaging; Embolic Protection Devices; Endovascular Procedures; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Lysine; Magnetic Resonance Angiography; Male; Molecular Imaging; Multivariate Analysis; Peroxidase; Plaque, Atherosclerotic; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Stents; Tandem Mass Spectrometry; Treatment Outcome | 2017 |
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells | 2018 |
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
Topics: Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fluorescence; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Optical Imaging; Plaque, Atherosclerotic; Prognosis; Prospective Studies; ROC Curve; Skin | 2019 |